Toutes les autorisations d'agir sur le capital proposées lors de la présente assemblée sont utilisables en période d'offre publique, ce qui en fait un arsenal anti-OPA non favorable aux intérêts des actionnaires.
Par ailleurs, la société propose la nomination de Pierre Olivier, le Directeur Général de sa filiale américaine. Or, le conseil est déjà composé en intégralité d'administrateurs sujets à conflits d'intérêts ; il serait préférable que la société propose la nomination d'administrateur compétents réellement indépendants.
Medicrea International SA is a France-based company that specializes in the design and manufacture of medical devices. The Company's product range includes polyaxial implants, impacted lumbar cage, polyaxial spine system, cervical compressive staples, cervical IBD, Lumbar IBD, cervical cage and bone substitutes. The Company has manufacturing facilities in La Rochelle, France. It is operational through such subsidiaries as Medicrea UK, based in the United Kingdom, Medicrea USA, based in the United States and Medicrea Technologies, based in France.
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.